Listen Get

Health Dividend

Keywords

war-on-disease, 1-percent-treaty, medical-research, public-health, peace-dividend, decentralized-trials, dfda, dih, victory-bonds, health-economics, cost-benefit-analysis, clinical-trials, drug-development, regulatory-reform, military-spending, peace-economics, decentralized-governance, wishocracy, blockchain-governance, impact-investing

That was the peace dividend: the money you get from buying 1% fewer explosions. Now here is the health dividend: what happens when you spend it on medicine instead.

Right now, somewhere in your regulatory system, a drug that already passed safety testing is sitting in a filing cabinet while the disease it treats keeps killing people. Somewhere else, a researcher with a promising compound for one of 6.65 thousand untreated diseases is filling out the same form for the fourth time. The health dividend is what happens when you stop doing this.

It is worth $84.8 quadrillion. That number is not a typo. I checked. Your economists checked. Everyone checked. It’s still that number. The rest of this chapter is the receipt.

From Explosions to Trial Slots

$27.2B arrives from the peace dividend. Investor and political allocations take their cut, leaving $21.8B for medical research (80% of the total). Your decentralized FDA136,137 takes $40M to keep the lights on. That leaves $21.7B for trial subsidies.

I am now going to show you what that money buys. I apologize in advance for the number of numbers. Your species requires receipts before it will believe anything, even things that are obviously true. Especially things that are obviously true.

Your current system charges $41K per patient in a clinical trial. I asked why and was told “regulatory compliance, site management, and monitoring overhead,” which I believe is the human phrase for “permission costs more than medicine.” Pragmatic trials, the kind your decentralized FDA runs, cost $929. At that price, $21.7B buys you 23.4 million patients/year trial slots per year.

Your species currently enrolls 1.9 million patients/year in clinical trials globally. The treaty adds 12.3x more capacity on top of that. Remember this number. Everything that follows depends on it.

The Waiting List

You met the queue in the untapped therapeutic frontier: 6.65 thousand diseases with zero approved treatments, and 15 getting their first treatment per year. At that rate, you clear the backlog in 443 years. I will let you sit with that number for a moment. It is longer than your species has had writing.

With $58.6 billion in annual R&D savings, you could run 10,000 trials and address 7,000 rare diseases. Currently you are spending that much to run far fewer trials for common diseases.

With $58.6 billion in annual R&D savings, you could run 10,000 trials and address 7,000 rare diseases. Currently you are spending that much to run far fewer trials for common diseases.

For context, 443 years ago, Shakespeare was writing plays, Galileo was building telescopes, and your species already had printing presses, universities, and intercontinental shipping. You just had not gotten around to curing most diseases. At this pace, you still will not for another 443 years.

Apply the 12.3x multiplier. Instead of 15 diseases getting their first treatment per year, you get 185 diseases/year. The queue clears in 36 years instead of 443 years. The average untreated disease gets its first treatment 204 years earlier. That is the difference between “your grandchildren might see a cure” and “you might see a cure.” On Wishonia, we consider this a meaningful distinction. On Earth, it apparently requires a 78-page chapter to justify.

Your species figured out how to split atoms in 6 years during a war, but letting a cancer patient take a pill that passed safety testing requires the gestation period of three consecutive elephants. The 12.3x multiplier compresses the elephant parade.

But trial capacity is only half the delay. Once a drug passes safety testing, your regulatory system sits on it for another 8.2 years to confirm it works well enough, while people who could be taking it die instead. Add the capacity acceleration and the efficacy lag together: 212 years of dying, condensed into not dying.

The Body Count

150 thousand deaths/day die from disease every day. While you were reading the previous section, approximately 300 of them did. They are not coming back to find out how the math turned out.

Not all of those deaths are currently preventable, but 92.6% are eventually avoidable with sufficient biomedical research. “Eventually avoidable” does not mean “currently preventable.” It means: given enough research, these diseases have biological solutions. The only category excluded is accidents (falling off things, being hit by things). Every disease, including aging, is a biological process, and biological processes are, in principle, fixable. This is the theoretical ceiling, not a near-term promise.

Over a 212-year timeline shift, the cumulative toll: 10.7 billion deaths. That is 565 billion DALYs of healthy life, and 1.93 quadrillion hours of suffering eliminated. These are cumulative, one-time benefits from permanently accelerating the discovery pipeline, the same methodology used to value smallpox eradication. Nobody objected to the methodology when it was used for smallpox. They will object now because the number is larger, which is a strange reason to object to saving more people.

The Price Tag on Not Being Dead

Your governments already put a price on human life when deciding whether to approve drugs, build highways, or regulate pollution. The standard rate: $150K per quality-adjusted life year. Your species finds this uncomfortable to discuss but does it constantly. You just prefer to do it in footnotes, where the dying can’t see.

The world loses 2.88 billion DALYs/year34. 92.6% are eventually avoidable with sufficient research. At $150K/QALY, that is $400T per year in welfare losses. Multiply by the 212-year timeline shift and you get the total economic value of the health dividend: $84.8 quadrillion.

“But that is more than global GDP!” Yes. GDP ($115T) measures market transactions. It does not measure the value of not being dead, not being in pain, and not watching your children die of treatable diseases. The $150K/QALY figure is not something I invented. I just multiplied it by the number of sick people, which is also not my fault.

The only debatable input is whether the timeline shift is really ~212 years. See the full derivation for how that number is calculated, and the Monte Carlo simulations for what happens when every input varies.

The Receipt

Conservative return on investment versus total return including not letting people die. One number is big, the other is astronomically big. Both beat war.

Conservative return on investment versus total return including not letting people die. One number is big, the other is astronomically big. Both beat war.

Your decentralized FDA costs $40M/year to operate. For reference, this is roughly what your species spends annually on Halloween costumes for dogs. Less than one fighter jet. Less than what FIFA spends on “hospitality” (your word for bribing officials in a building with chandeliers). A system that could test cures for 7 thousand diseases costs less to run than the outfits you put on animals that do not want to wear them.

The R&D savings alone are $58.6B/year, a 637:1 return without counting a single human life. Include the lives (which you would think someone would, but your species has a long history of not counting the people who die quietly), and the treaty’s total societal return hits 84.8M:1.

The cost per year of healthy life saved: $0.842. Anti-malaria bed nets, the gold standard of cost-effective interventions, cost $89 per DALY. This system operates at 50.3kx the cost-effectiveness, at vastly greater scale. This costs less per life-year than mosquito nets and nobody has heard of it. Your species has spent more money marketing energy drinks.

The total campaign investment: $1B. Even the worst case (everything goes wrong, adoption is terrible, the servers catch fire) still returns an estimated 66:1. Your worst medical outcome is better than your best military one.

Every day without this system costs $161M in wasted trial spending alone. The regulatory lag is not a safety feature. It is a waiting room where people die. You just gave it a nicer name.

For you personally: if diseases get cured even a few years earlier, the average human gains roughly 50,000 extra hours of life. You spent 17 minutes reading this chapter. That is a 176,000x return on your time. Your best investment ever was reading. I realize the irony, given that most of you stopped reading 12 paragraphs ago.

See impact.warondisease.org for derivations, Monte Carlo simulations, and the comparative cost-effectiveness table.